Skip to main content

Pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma

Access & Citations

  • 1238
    Article Accesses
  • 0
    Web of Science
  • 1
    CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.